T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
62 hedge funds and large institutions have $26.7M invested in T2 Biosystems, Inc in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
17% more funds holding
Funds holding: 53 → 62 (+9)
9% more capital invested
Capital invested by funds: $24.5M → $26.7M (+$2.19M)
3% less call options, than puts
Call options by funds: $333K | Put options by funds: $344K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.36M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$679K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$508K |
| 5 |
HF
HRT Financial
New York
|
+$233K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$422K |
| 2 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$350K |
| 3 |
SG Americas Securities
New York
|
-$269K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$159K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$91.8K |
TTOO Hedge Fund Activity: Q4 2020 in Review
62 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2020, worth a combined $26.7M — up 8.9% from $24.5M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TTOO positions and 9 closed out — a net gain of 10 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.36M. The largest seller was Squarepoint, cutting an estimated $422K.
- 62 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2020, up from 53 in Q3 2020.
- Funds reported $26.7M of T2 Biosystems, Inc stock for Q4 2020, up 8.9% quarter-over-quarter.
- 19 funds opened new T2 Biosystems, Inc positions in Q4 2020 and 9 closed out, a net change of +10 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2020 was Millennium Management, an estimated $1.36M added.
- The largest T2 Biosystems, Inc seller in Q4 2020 was Squarepoint, an estimated $422K sold.
Based on aggregated 13F filings for Q4 2020.